Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Remission of psoriatic lesions with muromonab-CD3 (orthoclone OKT3) treatment.

Literature DB >> 2502568

Remission of psoriatic lesions with muromonab-CD3 (orthoclone OKT3) treatment.

B G Weinshenker¹, B H Bass, G C Ebers, G P Rice.

Abstract

Entities: Chemical Disease

Mesh：

Substances：

Year: 1989 PMID： 2502568 DOI： 10.1016/s0190-9622(89)80200-2

Source DB: PubMed Journal: J Am Acad Dermatol ISSN： 0190-9622 Impact factor: 11.527

Keyword Cloud
Cited

× No keyword cloud information.

11 in total

Review 1. Immunological mechanisms involved in psoriasis.

Authors: C E Griffiths; J J Voorhees
Journal: Springer Semin Immunopathol Date: 1992

Review 2. Recent insights into the immunopathogenesis of psoriasis provide new therapeutic opportunities.

Authors: Brian J Nickoloff; Frank O Nestle
Journal: J Clin Invest Date: 2004-06 Impact factor: 14.808

3. Kinetics and regulation of human keratinocyte stem cell growth in short-term primary ex vivo culture. Cooperative growth factors from psoriatic lesional T lymphocytes stimulate proliferation among psoriatic uninvolved, but not normal, stem keratinocytes.

Authors: Z Bata-Csorgo; C Hammerberg; J J Voorhees; K D Cooper
Journal: J Clin Invest Date: 1995-01 Impact factor: 14.808

Review 4. Psoriasis, T cells and autoimmunity.

Authors: C E Griffiths; J J Voorhees
Journal: J R Soc Med Date: 1996-06 Impact factor: 18.000

5. The PKC inhibitor AEB071 may be a therapeutic option for psoriasis.

Authors: Hans Skvara; Markus Dawid; Elise Kleyn; Barbara Wolff; Josef G Meingassner; Hilary Knight; Thomas Dumortier; Tamara Kopp; Nasanin Fallahi; Georg Stary; Christoph Burkhart; Olivier Grenet; Juergen Wagner; Youssef Hijazi; Randall E Morris; Claire McGeown; Christiane Rordorf; Christopher E M Griffiths; Georg Stingl; Thomas Jung
Journal: J Clin Invest Date: 2008-09 Impact factor: 14.808

Review 6. A molecule solves psoriasis? Systemic therapies for psoriasis inducing interleukin 4 and Th2 responses.

Authors: Kamran Ghoreschi; Ulrich Mrowietz; Martin Röcken
Journal: J Mol Med (Berl) Date: 2003-07-18 Impact factor: 4.599

7. Effective treatment of psoriasis with etanercept is linked to suppression of IL-17 signaling, not immediate response TNF genes.

Authors: Lisa C Zaba; Mayte Suárez-Fariñas; Judilyn Fuentes-Duculan; Kristine E Nograles; Emma Guttman-Yassky; Irma Cardinale; Michelle A Lowes; James G Krueger
Journal: J Allergy Clin Immunol Date: 2009-11 Impact factor: 10.793